Alzamend Neuro, Inc.
ALZN · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,949 | $376 | $5,141 | $14,064 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $229 | $79 | $695 | $350 |
| Total Curr. Assets | $4,177 | $455 | $5,836 | $14,414 |
| Property Plant & Equip (Net) | $426 | $176 | $80 | $103 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | -$0 | $0 |
| Total NC Assets | $426 | $176 | $80 | $103 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4,603 | $632 | $5,916 | $14,516 |
| Liabilities | – | – | – | – |
| Payables | $635 | $2,925 | $2,870 | $1,163 |
| Short-Term Debt | $0 | $301 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $2 |
| Total Curr. Liab. | $635 | $3,226 | $2,870 | $1,165 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $1,163 |
| Other Liabilities | $0 | -$0 | $0 | -$1,163 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $635 | $3,226 | $2,870 | $1,165 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $10 | $10 |
| Retained Earnings | -$58,535 | -$54,020 | -$44,073 | -$29,194 |
| AOCI | $0 | $0 | -$14,883 | -$14,883 |
| Other Equity | $62,503 | $51,426 | $62,001 | $57,420 |
| Total Equity | $3,968 | -$2,594 | $3,046 | $13,352 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4,603 | $632 | $5,916 | $14,516 |
| Net Debt | -$3,949 | -$75 | -$5,141 | -$14,064 |